FIELD: medicine, preparative immunology.
SUBSTANCE: invention relates to a method for preparing IgG (immunoglobulin G) from blood plasma for medicinal using. Method involves the following steps: (1') removal of albumin with preparing IgG fraction followed by carrying out step (I) wherein IgG fraction prepared at stage (1') is concentrated; (2') this IgG fraction is purified on anion-exchange resin and unbound IgG fraction is collected; (3') this unbound IgG fraction is purified on cation-exchange resin and bound IgG fraction is collected and step (II) is carried out wherein pH value of IgG fraction eluted from cation-exchange resin at step (3') is brought about to 4 ± 0.1 and during all steps of the method pH value is maintained less 6.0; (4') virus in IgG fraction prepared from IgG fraction collected at step (3') is inactivated by using chemical reagents at temperature 30° ± 2°C for at least 4 h. Method provides preparing IgG that possesses anti-complementary activity less 1 titer value of complement providing 50% hemolysis (CH50)/mg of immunoglobulin.
EFFECT: improved preparing method.
7 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION AND OTHER IMMUNOGLOBULIN PREPARATIONS | 1999 |
|
RU2197500C2 |
METHOD FOR THE PRODUCTION OF IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION | 2019 |
|
RU2742655C1 |
PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
PREPARATION OF ANTIBODY IgG AND METHOD OF ITS PRODUCTION | 2005 |
|
RU2337109C2 |
METHOD OF PREPARING GAMMA-GLOBULIN SOLUTION DESIGNATED FOR INTRAVENOUS ADMINISTRATION AND PREPARATION PREPARING BY THIS METHOD | 1998 |
|
RU2198668C2 |
METHOD OF PRODUCING IMMUNOGLOBULINS | 2016 |
|
RU2708394C2 |
METHOD OF ALPHA-1-ANTITRYPSIN SOLUTION TREATMENT | 2004 |
|
RU2370500C2 |
METHOD OF PREPARING IMMUNOGLOBULINS FROM FRACTIONS FORMED IN HUMAN BLOOD PLASMA FRACTIONATION | 1996 |
|
RU2157240C2 |
METHOD OF IMMUNOGLOBULIN PURIFICATION (VERSIONS) | 2007 |
|
RU2332247C1 |
METHODS FOR REDUCING AND/OR REMOVING FXI AND FXIA FROM SOLUTIONS CONTAINING SAID CLOTTING FACTORS | 2011 |
|
RU2649363C2 |
Authors
Dates
2005-12-27—Published
2001-03-29—Filed